Gout — clinical cases
29 questions
Sample cases
- Case 1
A 52-year-old man with gout has had three acute flares of the first metatarsophalangeal joint in the past 12 months. He has no tophi and no radiographic joint damage. eGFR is 78 mL/min/1.73 m², and serum urate is 8.4 mg/dL (500 µmol/L). He currently takes no urate-lowering therapy (ULT). Which plan is most appropriate?
- A.Start urate-lowering therapy now because he has 2 or more flares per year
- B.Defer urate-lowering therapy until subcutaneous tophi develop
- C.Defer urate-lowering therapy until serum urate exceeds 9 mg/dL (535 µmol/L)
- D.Treat each flare as it occurs and avoid long-term therapy
- Case 2
A 45-year-old woman has a serum urate of 9.2 mg/dL (547 µmol/L) on routine blood work. She has never had a gout flare, has no tophi and no history of kidney stones. She asks whether she needs a medication to lower her uric acid. According to the ACR guideline, what is the best response?
- A.Start allopurinol 100 mg daily and titrate to a serum urate below 6 mg/dL
- B.Start febuxostat 40 mg daily because her urate exceeds 9 mg/dL
- C.Do not start pharmacologic urate-lowering therapy for asymptomatic hyperuricemia
- D.Start probenecid 500 mg daily because she has no kidney stones
- Case 3
A 60-year-old man presents with his first-ever gout flare (crystal-confirmed, left knee). He has chronic kidney disease with an eGFR of 42 mL/min/1.73 m² (stage 3b). Serum urate is 8.1 mg/dL (482 µmol/L). He has no tophi and no kidney stones. According to the ACR guideline, which statement about urate-lowering therapy is most appropriate?
- A.ULT is not indicated, because guidelines advise against ULT after a first flare in all patients
- B.ULT is reasonable now, because CKD stage 3 or worse favours starting after a first flare
- C.ULT should start only if a second flare occurs within the next 12 months
- D.ULT should start only if serum urate rises above 9 mg/dL (535 µmol/L)
